Daniele Scartoni
Overview
Explore the profile of Daniele Scartoni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
191
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Skinnerup Byskov C, Mortensen H, Biston M, Broggi S, Butof R, Canters R, et al.
Acta Oncol
. 2025 Mar;
64:406-414.
PMID: 40079654
Purpose: To present results from the trial radiotherapy quality assurance (RTQA) programme of the centres involved in the randomised phase-III PROton versus photon Therapy for esophageal Cancer - a Trimodality...
2.
Controversies in neuro-oncology: Focal proton versus photon radiation therapy for adult brain tumors
Eekers D, Zegers C, Ahmed K, Amelio D, Gupta T, Harrabi S, et al.
Neurooncol Pract
. 2024 Jul;
11(4):369-382.
PMID: 39006517
Radiation therapy (RT) plays a fundamental role in the treatment of malignant and benign brain tumors. Current state-of-the-art photon- and proton-based RT combines more conformal dose distribution of target volumes...
3.
Desideri I, Morelli I, Banini M, Greto D, Visani L, Nozzoli F, et al.
Radiother Oncol
. 2024 Jun;
197:110378.
PMID: 38857703
No abstract available.
4.
Desideri I, Morelli I, Banini M, Greto D, Visani L, Nozzoli F, et al.
Radiother Oncol
. 2024 Apr;
195:110271.
PMID: 38588920
Purpose: Re-irradiation (re-RT) for recurrent intracranial meningiomas is hindered by the limited radiation tolerance of surrounding tissue and the risk of side effects. This study aimed at assessing outcomes, toxicities...
5.
Mortensen H, Populaire P, Hoffmann L, Moeller D, Appelt A, Nafteux P, et al.
Radiother Oncol
. 2023 Nov;
190:109980.
PMID: 37935284
No abstract available.
6.
Scartoni D, Giacomelli I, Pertile R, Vennarini S, Feraco P, Picori L, et al.
Acta Oncol
. 2023 Aug;
62(9):1096-1101.
PMID: 37526998
No abstract available.
7.
Becherini C, Lancia A, Detti B, Lucidi S, Scartoni D, Ingrosso G, et al.
Strahlenther Onkol
. 2023 Jun;
199(12):1173-1190.
PMID: 37347290
Objective: Tumor-associated macrophages (TAMs) are the most represented cells of the immune system in the tumor microenvironment (TME). Besides its effects on cancer cells, radiation therapy (RT) can alter TME...
8.
Detti B, Carnevale M, Lucidi S, Burchini L, Caini S, Orsatti C, et al.
Front Oncol
. 2023 Apr;
13:1079808.
PMID: 37025599
Purpose: Biochemical recurrence (BR) occurs in up to 40% of patients with prostate cancer (PCa) treated with primary radical prostatectomy (RP). Choline PET/CT may show, in a single-step examination, the...
9.
Placidi L, Righetto R, Vecchi C, Zara S, Alparone A, Moretti R, et al.
Phys Med
. 2022 Dec;
105:102503.
PMID: 36529006
Purpose: To evaluate the feasibility of comprehensive automation of an intra-cranial proton treatment planning. Materials And Methods: Class solution (CS) beam configuration selection allows the user to identify predefined beam...
10.
Dionisi F, Scartoni D, Fracchiolla F, Giacomelli I, Siniscalchi B, Goanta L, et al.
Front Oncol
. 2022 Aug;
12:959552.
PMID: 36003769
Liver cancer represents one of the most common causes of death from cancer worldwide. Hepatocellular carcinoma (HCC) accounts for 90% of all primary liver cancers. Among local therapies, evidence regarding...